Aclaris Therapeutics, Inc. (ACRS) Operating income 2016–2025
Aclaris Therapeutics, Inc. (ACRS) annual operating income history from SEC filings — each fiscal year as reported.
-$76.4MFY2025 · since FY2016: -$48.6M → -$76.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$76.4M | +46.2% |
| FY2024 | -$141.9M | -45.8% |
| FY2023 | -$97.4M | -8.4% |
| FY2022 | -$89.9M | -0.1% |
| FY2021 | -$89.7M | -76.2% |
| FY2020 | -$50.9M | +54.2% |
| FY2019 | -$111.1M | -31.0% |
| FY2018 | -$84.8M | -56.0% |
| FY2017 | -$54.4M | -11.9% |
| FY2016 | -$48.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice